Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder
- 9 March 2006
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 187 (1) , 68-72
- https://doi.org/10.1007/s00213-006-0349-8
Abstract
To determine whether variation in the serotonin transporter gene promoter (5HTTLPR) influences the efficacy of selective serotonin reuptake inhibitors (SSRIs) in generalized social anxiety disorder (GSAD).Keywords
This publication has 29 references indexed in Scilit:
- Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter GeneNeuropsychopharmacology, 2005
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- An evaluation of paroxetine in generalised social anxiety disorderExpert Opinion on Pharmacotherapy, 2005
- Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosaMolecular Psychiatry, 2005
- Comorbidity of Anxiety Disorders With Anorexia and Bulimia NervosaAmerican Journal of Psychiatry, 2004
- Pharmacotherapy for social anxiety disorderPublished by Wiley ,2004
- Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobiaNeuroscience Letters, 2004
- Predictors of Response in Generalized Social PhobiaJournal of Clinical Psychopharmacology, 2004
- Predictors of Response to Pharmacotherapy in Social Anxiety DisorderThe Journal of Clinical Psychiatry, 2002
- Disability and Quality of Life in Social Phobia: Epidemiologic FindingsAmerican Journal of Psychiatry, 2000